Evaluation Effectiveness and Safety of (cTACE or DEB-TACE + FOLFOX Regimen HAIC) Combined With Camrelizumab and Apatinib Mesylas in the Treatment of Advanced Hepatocellular Carcinoma
Clinical trial NCT04479527 · UNKNOWN
Trial details
- NCT number
- NCT04479527
- Sponsor
- Peking University Cancer Hospital & Institute
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-01
- Primary completion
- 2023-08-01
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.